Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology Jan 20;34(3):280-285
- Year
- 2016
- Research Committee(s)
- Genitourinary
- PMID
- PMID26552421
- PMC
- PMC5242560
- Study Number(s)
- SWOG-9346
Evaluating intermittent androgen deprivation therapy phase III clinical trials: “The devil is in the details”
- Journal / Conference
- Future Oncology, May;12(10):1219-1231; 2016 Mar 8 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID26952901
- PMC
- PMC4864045
- Study Number(s)
- S1204
Stepwise development of a cancer care delivery research study to evaluate viral infections in cancer patients: SWOG S1204
- Journal / Conference
- Journal of the American Geriatrics Society Dec;64(12):2472-2478; 2016 Nov 1[Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27801937
- PMC
- PMC5173398
- Study Number(s)
- S0000A
Self-reported sleep apnea and dementia risk: Findings from The Prevention of Alzheimer’s Disease with Vitamin E and Selenium Trial
- Journal / Conference
- International Journal of Radiation Oncology, Biology, and Physics, Jun 1;95(2):703-706
- Year
- 2016
- Research Committee(s)
- Genitourinary
- PMID
- PMID27020106
- PMC
- PMC5126649
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Validating a local failure risk stratification for use in prospective studies of adjuvant radiation therapy for bladder cancer
- Journal / Conference
- British Journal of Haematology, Jan;172(2):208-218; 2015 Oct 22[Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID26492567
- PMC
- PMC4710555
- Study Number(s)
- S0601
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for mantle cell lymphoma: SWOG S0601
- Journal / Conference
- Journal of Thoracic Oncology, Mar;11(3):420-425; 2015 Dec 24[Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lung
- PMID
- PMID26725184
- PMC
- PMC4775366
- Study Number(s)
- S0709
SWOG S0709: Randomized phase II trial of erlotinib vs. erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay
- Journal / Conference
- Leukemia & Lymphoma Oct;57(10):2359-2369; 2016 Jan 12:1-11 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID26758422
- PMC
- PMC5140034
- Study Number(s)
- S0520
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive b-cell lymphomas: SWOG S0520
- Journal / Conference
- Biology of Blood and Marrow Transplantation Aug;22(8):1440-1448;2016 Apr 23 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27118571
- PMC
- PMC4949103
Reduced intensity conditioning with high dose RTX yields excellent outcomes after allogeneic hematopoietic cell transplantation for relapsed follicular lymphoma: a phase II multicenter trial from the blood and marrow transplant network
- Journal / Conference
- JAMA Oncology, Jan 1;2(1):137-139
- Year
- 2016
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID26468994
- PMC
- PMC4824189
- Study Number(s)
- S0316
Patient income level and cancer clinical trial participation in a prospective survey study [Research Letter]
- Journal / Conference
- British Journal of Haematology Sep;174(5):686-691; 2016 Apr 13 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27072903
- PMC
- PMC5125530
- Study Number(s)
- S9704